Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

Share Price is delayed by 15 minutes
Get Live Data
12.60    -0.05 (-0.40%)
Bid:
12.60
Ask:
12.95
Spread: 0.35 (2.778%)
Market Cap: £42.85m
BVC Live PriceLast checked at - London Stock Exchange

Intraday Batm Advanced Share Chart

HCV Testing Certification

2 May 2012 07:00

RNS Number : 5067C
BATM Advanced Communications Ld
02 May 2012
 



2 May 2012

 

BATM Advanced Communications Limited

CE certification for HCV (Hepatitis C) screening kit

 

BATM Advanced Communications Limited ("the Company") (LSE: BVC), a leading designer and producer of broadband data and telecoms systems and medical laboratory equipment, is pleased to announce that its wholly owned subsidiary Adaltis, a manufacturer of medical diagnostics equipment, has received CE certification for its HCV (Hepatitis C) Screening Kit.

 

The kit is a fourth generation Enzyme Immunoassay (Elisa) kit for the determination of antibodies to Hepatitis's C virus in human plasma or serum. Testing in external, independent labs has shown performance results of 100% for diagnostic sensitivity and 99.5% for diagnostic specificity, clearly marking this screening kit as the top of its class. This level of accuracy will ensure that patients receive reliable diagnoses and that laboratories are spared the significant and needless expense of repeat testing.

 

The kit enables two different method protocols, one especially developed for the Chinese market and a shorter version for the rest of the world.

 

This certification follows the Company's announcement of 23 March 2012 that it had received CE certification for its Detect 4 HIV Total Screening Kit.

 

Initial deliveries of the new kit will start in the second quarter of this year, with an increasing buildup of production through the fourth quarter and into next year.

 

Dr Zvi Marom, Chief Executive, of BATM commented:

"We're delighted to have received certification for the HCV screening kit which comes just after the clearance for our HIV kit. This is further evidence of the momentum that we are building within our medical division as we continue to add to our portfolio of products."

 

 

- Ends -

 

For further information:

 

Enquiries

 

BATM Advanced Communications +972 9866 2527   

Ofer Bar-Ner, CFO

 

Newgate Threadneedle 020 7653 9850

Josh Royston / Graham Herring

 

finnCap 020 7220 0500

Marc Young / Brian Patient

 

Shore Capital 020 7408 4090 

Pascal Keane

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSAFLFFESEEI
Date   Source Headline
24th Apr 20197:00 amRNSAnnual Financial Report - DTR 6.3.5 Disclosure
16th Apr 20197:00 amRNSNew Armed Forces Customer for Cyber Security
5th Apr 20197:00 amRNSReceipt of $14.5m investment in Ador Diagnostics
2nd Apr 20197:00 amRNSHolding(s) in Company
20th Mar 20191:14 pmRNSShare Option Exercise, Issue of Equity and TVR
6th Mar 20197:00 amRNSFinal Results
5th Mar 20197:00 amRNSFirst International Agri-Waste Treatment Contract
27th Feb 20194:34 pmRNSShare Option Exercise, Issue of Equity and TVR
18th Feb 20197:00 amRNSNotice of Results
18th Feb 20197:00 amRNS$3.3m Follow-On Cyber Security Order
4th Feb 20197:00 amRNSAward of $3.2m Cyber Security Contract
28th Jan 20197:00 amRNSInvestment Agreement for $30m
16th Jan 20197:00 amRNSBATM upgrades Kenya education network
27th Dec 20187:00 amRNSHolding(s) in Company
24th Dec 20187:00 amRNSHoldings in Company
13th Dec 201811:31 amRNSShare Option Exercise, Issue of Equity and TVR
3rd Dec 20187:00 amRNSAdvancement of strategic partnership with Arm
29th Nov 20187:00 amRNSCapital Markets Day
28th Nov 201812:10 pmRNSResult of AGM and Directorate Change
26th Nov 20189:56 amRNSHolding(s) in Company
5th Nov 20187:00 amRNSNotice of AGM and Directorate Change
25th Oct 20187:00 amRNSHolding(s) in Company
22nd Oct 20187:00 amRNSHolding(s) in Company
18th Oct 20182:48 pmRNSHolding(s) in Company
11th Oct 20189:44 amRNSOptions Exercise, Issue of Equity and TVR
28th Aug 20187:00 amRNSInterim Results
20th Aug 20187:00 amRNSNotice of Results
8th Aug 20188:28 amRNSAgreement with Cellcom to sell IBC holdings
19th Jul 20181:08 pmRNSShare Option Exercise, Issue of Equity and TVR
17th Jul 20187:00 amRNSLaunch of SD-WAN solution with FatPipe Networks
22nd Jun 20187:00 amRNSHolding(s) in Company
11th Jun 20187:00 amRNSNew Follow-On Cyber Security Contract
6th Jun 201810:04 amRNSResult of Meeting and Grant of Options
4th Jun 20187:00 amRNSJDA and Strategic Investment
8th May 20183:06 pmRNSNotice of Shareholders' Meeting and Options Grant
30th Apr 20182:25 pmRNSAnnual Financial Report - DTR 6.3.5 Disclosure
5th Mar 20187:00 amRNSFinal Results
19th Feb 20187:00 amRNSTrading Update
8th Jan 20187:00 amRNSBATM awarded $4m cyber security contract
13th Dec 20177:00 amRNSLaunch of vSecurity solution with Trend Micro
4th Dec 20177:00 amRNSSale of Property
22nd Nov 20177:00 amRNSKey partnerships established in NFV market
23rd Oct 20177:00 amRNSHolding(s) in Company
18th Oct 20173:22 pmRNSResult of AGM
17th Oct 20177:00 amRNSEuropean government cyber security contract
11th Oct 20177:00 amRNSLaunch of industry's first Arm-based uCPE with NXP
14th Sep 20177:00 amRNSNotice of AGM and Grant of Options
4th Sep 20177:00 amRNSICT Framework Agreement
1st Sep 20172:01 pmRNSHolding(s) in Company
30th Aug 20177:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.